Marshall Wace’s Usana Health Sciences USNA Stock Holding History

Marshall Wace’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,464	Closed	-$288K	–	3504
2025 Q3	$288K	Buy	+10,464	New	+$322K	﹤0.01%	2445
2025 Q2	–	Sell	-9,986	Closed	-$269K	–	3204
2025 Q1	$269K	Sell	9,986 -7,244	-42%	-$229K	﹤0.01%	2303
2024 Q4	$618K	Buy	+17,230	New	+$644K	﹤0.01%	1956
2024 Q3	–	Sell	-11,602	Closed	-$525K	–	2981
2024 Q2	$525K	Buy	+11,602	New	+$534K	﹤0.01%	1943
2019 Q2	–	Sell	-42,031	Closed	-$3.52M	–	1863
2019 Q1	$3.52M	Buy	+42,031	New	+$4.39M	0.03%	570
2017 Q1	–	Sell	-51,019	Closed	-$3.12M	–	752
2016 Q4	$3.12M	Sell	51,019 -7,061	-12%	-$460K	0.02%	563
2016 Q3	$4.02M	Buy	+58,080	New	+$3.83M	0.03%	452

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's USNA Position: Q4 2025 in Review

Marshall Wace sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 10,464 shares — an estimated $288K sold.

Marshall Wace first reported a position in USNA in Q3 2016 and held it in 7 quarters. The position peaked at $4.02M in Q3 2016. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

Marshall Wace reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
Marshall Wace sold 10,464 Usana Health Sciences shares in Q4 2025, an estimated $288K.
Marshall Wace first reported a position in Usana Health Sciences in Q3 2016 and held it in 7 quarters.
Marshall Wace's Usana Health Sciences position peaked at $4.02M in Q3 2016.
121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.